Niagen Bioscience Inc (NASDAQ:NAGE) currently has a daily average trading volume of 1.07M but it saw 1043648 shares traded in last market. With a market cap of 795.57M USD, the company’s current market price of $10.10 came rising about 3.80 while comparing to the previous closing price of $9.73. In past 52 weeks, the stock remained buoying in the range of price level as high as $10.00 and as low as $2.31.
Taking a look at 20-day trading activity of Niagen Bioscience Inc (NAGE) gives us an average price of $8.03, while its current price level is 1.00% below from 52-week high level whereas it is 338.18% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $7.48 while that of 200 days or SMA-200 reads an average of $5.52. A closer look into the stock’s movement over the week reveals that its volatility is standing at 6.61% during that period while stretching the period over a month that decreases to 5.51%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 75.13 which implies that the stock is in overbought territory.
B. Riley Securities downgraded its recommendation for the stock as a “Neutral” from “Buy” on August 11, 2022 while assigning a price target range of $6-$2.40. ROTH Capital issued its recommendations for the stock as it initiated the price target for the stock is $7.
Over the week, NAGE’s stock price is moving 19.53% up while it is 64.50% when we observe its performance for the past one month. Year-to-date it is 90.39% up and over the past year, the stock is showing an upside performance of 195.32%.
Currently, Niagen Bioscience Inc’s total number of outstanding shares is 78.43M with 34.44% of that held by the insiders while 31.20% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 24.35% and return on equity (ROE) at 33.47%. It has a price to earnings ratio (P/E ratio) of 58.48 while having a 43.93 of forward P/E ratio. Stock’s beta reads 2.03. Stock has a price to book (P/B) ratio of 14.31 while price to sale or P/S ratio amounts to 7.37. Its return on asset (ROA) is 20.83% on average.
